REGENXBIO Inc. logo

REGENXBIO Inc.

NASDAQ:RGNX

Overview | Financials
Company Name REGENXBIO Inc.
Symbol RGNX
Currency USD
Price 13.15
Market Cap 647,716,400
Dividend Yield 0%
52-week-range 11.83 - 28.8
Industry Biotechnology
Sector Healthcare
CEO Mr. Kenneth T. Mills
Website https://www.regenxbio.com

An error occurred while fetching data.

About REGENXBIO Inc.

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform,

Related Stocks

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

48.98 USD

National Research Corporation logo

National Research Corporation

NRC

25.35 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

20.27 USD

Morphic Holding, Inc. logo

Morphic Holding, Inc.

MORF

28.76 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

27 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

6.82 USD

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI

6.07 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

13.3 USD

Cerus Corporation logo

Cerus Corporation

CERS

1.84 USD

Financials

Numbers are in millions USD

Numbers are in millions USD